On October 24,2017,the officers of DENDRIX visited Beroni Group. Beroni Group established a strategic partnership with DENDRIX on the development of human health projects such as immune cell medicine and stem cell fields.Mr. Shigeru Hirabayashi，CEO of DENDRIX，Mr.Katsuo Noguchi，CSO of DENDRIX and their officers attended this meeting.
Mr. Boqing Zhang send his respect to all the guests from Japan.Mr.Shigeru Hirabayashi,CEO of DENDRIX, introduced the strategic development plan of DENDRIX. He is looking forward to further strengthening cooperation and communication with Beroni Group. Mr.Katsuo Noguchi，CSO of DENDRIX,introduced the development of immunotherapy.
Beroni Group further understands the scientific breakthrough and development prospect of DENDRIX in immunotherapy field through friendly communication. The two sides have highly consistent in business philosophy and development goals.
Mr. Boqing Zhang said that the era of Precision Medicine has arrived, the clinical application of immune cell therapy will surely be the gospel of cancer patients.Beroni Group will built a platform for the immune cell therapy with DENDRIX, which will contribute to the development of health .